Microbial Biotechnology,
Journal Year:
2025,
Volume and Issue:
18(1)
Published: Jan. 1, 2025
ABSTRACT
Advancing
microbiome–gut–brain
axis
science
requires
systematic,
rational
and
translational
approaches
to
bridge
the
critical
knowledge
gaps
currently
preventing
full
exploitation
of
gut
microbiome
as
a
tractable
therapeutic
target
for
gastrointestinal,
mental
brain
health.
Current
research
is
still
marked
by
many
open
questions
that
undermine
widespread
application
humans.
For
example,
lack
mechanistic
understanding
probiotic
effects
means
it
remains
unclear
why
even
apparently
closely
related
strains
exhibit
different
in
vivo.
live
microbial
psychobiotics,
consensus
on
their
adjunct
treatments
conventional
neuromodulators,
use
unmedicated
populations
or
at‐risk
cohorts
with
sub‐clinical
symptomatology
warranted.
This
missing
information
both
sides
equation
when
treating
central
nervous
system
(CNS)
conditions
makes
psychobiotic
challenging,
especially
compared
other
pharmaceutical
functional
food
approaches.
Expediting
transition
from
positive
preclinical
data
proven
benefits
humans
includes
interpreting
promises
pitfalls
animal
behavioural
assays,
well
navigating
mechanism‐informed
decision
making
select
right
microbe(s)
job.
In
this
review,
we
consider
how
these
decisions
can
be
supported
light
accrued
range
clinical
studies
across
healthy,
pathological
study
populations,
where
specific
have
been
evaluated
context
gastrointestinal
physiology,
function
behaviour.
Examples
successful,
partial
unsuccessful
translation
bench
bedside
are
considered.
We
also
discuss
developments
silico
analyses
enhanced
our
moved
towards
pinpointing
host–microbe
interactions
most
important
optimal
gut–brain
function.
Combining
assays
vitro
ex
vivo
domains
incorporating
model
organisms
prime
discovery
pipelines
promising
rationally
selected
candidates.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Feb. 16, 2024
Abstract
The
human
gastrointestinal
tract
is
populated
with
a
diverse
microbial
community.
vast
genetic
and
metabolic
potential
of
the
gut
microbiome
underpins
its
ubiquity
in
nearly
every
aspect
biology,
including
health
maintenance,
development,
aging,
disease.
advent
new
sequencing
technologies
culture-independent
methods
has
allowed
researchers
to
move
beyond
correlative
studies
toward
mechanistic
explorations
shed
light
on
microbiome–host
interactions.
Evidence
unveiled
bidirectional
communication
between
central
nervous
system,
referred
as
“microbiota–gut–brain
axis”.
microbiota–gut–brain
axis
represents
an
important
regulator
glial
functions,
making
it
actionable
target
ameliorate
development
progression
neurodegenerative
diseases.
In
this
review,
we
discuss
mechanisms
As
provides
essential
cues
microglia,
astrocytes,
oligodendrocytes,
examine
communications
microbiota
these
cells
during
healthy
states
Subsequently,
diseases
using
metabolite-centric
approach,
while
also
examining
role
microbiota-related
neurotransmitters
hormones.
Next,
targeting
intestinal
barrier,
blood–brain
meninges,
peripheral
immune
system
counteract
dysfunction
neurodegeneration.
Finally,
conclude
by
assessing
pre-clinical
clinical
evidence
probiotics,
prebiotics,
fecal
transplantation
A
thorough
comprehension
will
foster
effective
therapeutic
interventions
for
management
Trends in Food Science & Technology,
Journal Year:
2023,
Volume and Issue:
138, P. 178 - 198
Published: June 11, 2023
The
human
gut
hosts
complex
microbial
communities,
which
are
linked
to
health
and
disease.
microbiota
is
continuously
reshaped
by
multiple
environmental
factors,
especially
diet.
Gut
dysbiosis
may
promote
various
metabolic,
neurological,
intestinal,
cardiovascular
diseases,
even
tumor
development.
Probiotics
have
shown
promising
prophylactic,
mitigating,
or
curative
effects
when
use
as
nutrient
supplements
adjunctive
therapy.
These
beneficial
and/or
symptom
alleviation
often
accompanied
microbiome
metabolome
changes.
Differing
from
other
published
review
articles,
here
we
summarized
the
latest
knowledge
of
evidence-based
health-promoting
probiotics
scouring
literature
recent
animal
probiotic
intervention
studies.
To
elucidate
mechanisms
in
enhancing
intestinal
homeostasis,
barrier
function,
host
immunity,
through
modulating
its
metabolites.
Meanwhile,
also
discussed
challenges
data
analysis
clinical
research
comparison
between
laboratories,
provides
an
outlook
for
future
perspectives
applications
probiotics.
achieved
modulation.
Current
discussed.
Finally,
provided.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(6)
Published: Nov. 4, 2023
The
gut
microbiota
and
its
homeostasis
play
a
crucial
role
in
human
health.
However,
for
some
diseases
related
to
the
microbiota,
current
traditional
medicines
can
only
relieve
symptoms,
it
is
difficult
solve
root
causes
or
even
cause
side
effects
like
disturbances
microbiota.
Increasing
clinical
studies
evidences
have
demonstrated
that
probiotics,
prebiotics,
postbiotics
prevent
treat
various
diseases,
but
currently
they
be
used
as
dietary
supplements
rather
than
medicines,
which
restricts
application
of
probiotics
field
medicine.
Here,
this
review
analyzes
importance
health
problems
systematically
summarizes
effectiveness
mechanisms
maintaining
treating
based
on
animal
models
trials.
And
research
outcomes
development
trends
field,
challenges
prospects
their
health,
alleviating
are
analyzed.
It
hoped
promote
disease
treatment
open
up
new
frontiers
probiotic
research.
Life,
Journal Year:
2024,
Volume and Issue:
14(5), P. 559 - 559
Published: April 26, 2024
The
gastrointestinal
tract
is
home
to
trillions
of
diverse
microorganisms
collectively
known
as
the
gut
microbiota,
which
play
a
pivotal
role
in
breaking
down
undigested
foods,
such
dietary
fibers.
Through
fermentation
these
food
components,
short-chain
fatty
acids
(SCFAs)
acetate,
propionate,
and
butyrate
are
produced,
offering
numerous
health
benefits
host.
production
absorption
SCFAs
occur
through
various
mechanisms
within
human
intestine,
contingent
upon
types
fibers
reaching
specific
engaged
fermentation.
Medical
literature
extensively
documents
supplementation
SCFAs,
particularly
butyrate,
treatment
gastrointestinal,
metabolic,
cardiovascular,
gut-brain-related
disorders.
This
review
seeks
provide
an
overview
dynamics
involved
gut.
Additionally,
it
will
focus
on
roles
promoting
metabolic
health,
well
their
current
therapeutic
implications.
Journal of Advanced Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 1, 2024
Population
aging
has
become
a
primary
global
public
health
issue,
and
the
prevention
of
age-associated
diseases
prolonging
healthy
life
expectancies
are
particular
importance.
Gut
microbiota
emerged
as
novel
target
in
various
host
physiological
disorders
including
aging.
Comprehensive
understanding
on
changes
gut
during
aging,
characteristics
centenarians,
can
provide
us
possibility
to
achieving
or
intervene
pathological
through
microbiota-directed
strategies.
This
review
aims
summarize
associated
with
explore
potential
biomarkers
address
microbiota-associated
mechanisms
focusing
intestinal
barrier
immune
status.
By
summarizing
existing
effective
dietary
strategies
interventions,
probability
developing
diet
targeting
future
is
provided.
focused
three
key
notions:
Firstly,
new
for
regulating
status
lifespan,
its
closely
related
age.
Thus,
we
summarized
aging-associated
features
at
levels
genus/species
important
metabolites
comparing
differences
among
elderly
people
younger
people.
Secondly,
exploring
discussing
using
regime/components
targeted
aging-related
promote
human
lifespan.
Thirdly,
intervention
effectively
improve
imbalance
such
probiotics,
prebiotics,
postbiotics,
but
their
effects
vary
among.
npj Science of Food,
Journal Year:
2022,
Volume and Issue:
6(1)
Published: Nov. 15, 2022
Abstract
Probiotics
are
increasingly
used
as
adjunctive
therapy
to
manage
gastrointestinal
diseases,
such
ulcerative
colitis.
However,
probiotic
use
has
posed
some
safety
concerns.
Thus,
postbiotics
proposed
alternatives
probiotics
in
clinical
applications.
no
study
directly
compared
the
benefits
of
and
postbiotics.
This
beneficial
effect
derived
from
strain,
Bifidobacterium
adolescentis
B8589,
a
dextran
sulfate
sodium
(DSS)-induced
experimental
colitis
mouse
model.
Four
groups
mice
(
n
=
7
per
group)
were
included
this
work:
Control
(received
water
plus
saline),
DSS
without
postbiotic/probiotic),
Postbiotic
postbiotic),
Probiotic
probiotic).
Our
results
showed
that
intragastric
administration
both
postbiotic
ameliorated
colitis,
reflected
by
decreased
histology
scores
with
group
P
<
0.05).
The
fecal
microbiota
alpha
diversity
was
not
significantly
affected
DSS-,
postbiotic,
or
treatment.
treatment
stronger
effects
on
modulating
beta
diversity,
composition,
metagenomic
potential
than
Overall,
our
findings
suggested
had
similar
ability
improve
disease
phenotype
but
distinct
regulate
gut
metabolic
pathways
context
In
view
smaller
concern
its
modulatory
host
microbiota,
we
propose
be
considered
for
next-generation
biotherapeutics
managing
even
other
diseases.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(20), P. 12289 - 12289
Published: Oct. 14, 2022
The
bidirectional
interaction
between
the
gut
microbiota
(GM)
and
Central
Nervous
System,
so-called
brain
axis
(GMBA),
deeply
affects
function
has
an
important
impact
on
development
of
neurodegenerative
diseases.
In
Parkinson’s
disease
(PD),
gastrointestinal
symptoms
often
precede
onset
motor
non-motor
manifestations,
alterations
in
GM
composition
accompany
pathogenesis.
Several
studies
have
been
conducted
to
unravel
role
dysbiosis
intestinal
permeability
PD
progression,
but
therapeutic
diagnostic
applications
modifying
approaches
remain
be
fully
elucidated.
After
a
brief
introduction
involvement
GMBA
disease,
we
present
evidence
for
leaky
patients.
According
these
data,
then
review
potential
GM-based
signatures
serve
as
biomarkers
highlight
emerging
probiotics,
prebiotics,
antibiotics,
dietary
interventions,
fecal
transplantation
supportive
PD.
Finally,
analyze
mutual
influence
commonly
prescribed
medications
gut-microbiota,
offer
insights
also
nasal
oral
pathology,
thus
providing
comprehensive
up-to-date
overview
microbial
features
diagnosis
treatment.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(21), P. 4678 - 4678
Published: Nov. 4, 2022
There
is
mounting
evidence
that
the
microbiota-gut-brain
axis
(MGBA)
critical
in
pathogenesis
and
progression
of
Parkinson's
disease
(PD),
suggesting
probiotic
therapy
restoring
gut
microecology
may
slow
down
progression.
In
this
study,
we
examined
disease-alleviating
effects
Bifidobacterium
breve
CCFM1067,
orally
administered
for
5
weeks
a
PD
mouse
model.
Our
study
shows
supplementation
with
B.
CCFM1067
protected
dopaminergic
neurons
suppressed
glial
cell
hyperactivation
neuroinflammation
mice.
addition,
antioxidant
capacity
central
nervous
system
was
enhanced
oxidative
stress
alleviated.
Moreover,
blood-brain
intestinal
barriers
from
damage
MPTP-induced
The
results
fecal
microbiota
analysis
showed
intervention
could
act
on
microecological
imbalance
microbiota,
suppressing
number
pathogenic
bacteria
(Escherichia-Shigella)
while
increasing
beneficial
(Bifidobacterium
Akkermansia)
increase
short
chain
fatty
acids
(acetic
butyric
acids)
explain
anti-inflammatory
action
or
brain
conclusion,
demonstrated
which
can
prevent
treat
by
modulating
gut-brain
axis,
be
utilized
as
possible
new
oral
supplement
therapy.
Nutrients,
Journal Year:
2022,
Volume and Issue:
15(1), P. 51 - 51
Published: Dec. 22, 2022
Probiotics
could
improve
cognitive
functions
in
patients
with
neurological
disorders
such
as
Alzheimer’s
disease,
but
the
effects
on
function
healthy
older
adults
without
impairment
need
further
study.
The
purpose
of
this
study
was
to
investigate
effect
Bifidobacterium
longum
BB68S
(BB68S)
among
impairment.
A
randomized,
double-blind,
placebo-controlled
trial
conducted
60
who
were
divided
into
probiotic
or
placebo
groups
and
required
consume
either
a
sachet
(BB68S,
5
×
1010
CFU/sachet)
once
daily
for
8
weeks.
Montreal
Cognitive
Assessment
(MoCA)
used
an
inclusion
screening
tool
screen
elderly
participants
our
study,
Repeatable
Battery
Neuropsychological
Status
(RBANS)
assess
subjects
before
after
intervention
assessment
tool.
significantly
improved
subjects’
(total
RBANS
score
increased
by
18.89
points
intervention,
p
<
0.0001),
especially
immediate
memory,
visuospatial/constructional,
attention,
delayed
memory
domains.
relative
abundances
beneficial
bacteria
Lachnospira,
Bifidobacterium,
Dorea,
Cellulosilyticum,
while
decreasing
those
related
cognition
impairment,
Collinsella,
Parabacteroides,
Tyzzerella,
Bilophila,
unclassified_c_Negativicutes,
Epulopiscium,
Porphyromonas,
Granulicatella.
In
conclusion,
along
having
regulatory
their
gut
microbiota.
This
supports
probiotics
strategy
promote
aging
advances
research.